Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'

Linda Al-Hassany; Deirdre M. Boucherie; Emile G.M. Couturier; Antoinette MaassenVanDenBrink

doi:10.1177/03331024241293104

Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'

Linda Al-Hassany
, Deirdre M. Boucherie
, Emile G.M. Couturier
, Antoinette MaassenVanDenBrink^*

^*Corresponding author for this work

Internal Medicine

Neurologie Centrum Amsterdam

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

39 Downloads (Pure)

Original language	English
Journal	Cephalalgia : an international journal of headache
Volume	44
Issue number	10
Early online date	24 Oct 2024
DOIs	https://doi.org/10.1177/03331024241293104
Publication status	Published - Oct 2024

Access to Document

10.1177/03331024241293104Licence: CC BY

Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’Final published version, 159 KBLicence: CC BY

Cite this

@article{4e7cb463f0374d98aca65083dfa31b59,

title = "Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'",

author = "Linda Al-Hassany and Boucherie, \{Deirdre M.\} and Couturier, \{Emile G.M.\} and Antoinette MaassenVanDenBrink",

year = "2024",

month = oct,

doi = "10.1177/03331024241293104",

language = "English",

volume = "44",

journal = "Cephalalgia : an international journal of headache",

issn = "0333-1024",

publisher = "SAGE Publications Ltd",

number = "10",

}

Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'. / Al-Hassany, Linda ; Boucherie, Deirdre M.; Couturier, Emile G.M. et al.
In: Cephalalgia : an international journal of headache, Vol. 44, No. 10, 10.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'

AU - Al-Hassany, Linda

AU - Boucherie, Deirdre M.

AU - Couturier, Emile G.M.

AU - MaassenVanDenBrink, Antoinette

PY - 2024/10

Y1 - 2024/10

UR - https://www.scopus.com/pages/publications/85207700249

U2 - 10.1177/03331024241293104

DO - 10.1177/03331024241293104

M3 - Comment/Letter to the editor

C2 - 39445402

AN - SCOPUS:85207700249

SN - 0333-1024

VL - 44

JO - Cephalalgia : an international journal of headache

JF - Cephalalgia : an international journal of headache

IS - 10

ER -

Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'

Access to Document

Other files and links

Cite this